Interestingly, the sweat chloride changes, although highly significant in both groups, was less marked in those with only a single copy of F508del , confirming clinical trial findings in a real-world setting and suggesting there may be further scope for improved therapy in this group in the future.
← all excerpts
Phoenix from the Ashes: Celebrating the 2023 North American Cystic Fibrosis Conference.
1
—
—